These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1459194)
1. Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line. Kuwahara T; Kudoh T; Nagase H; Takamiya M; Nakano A; Ohtsuka T; Yoshizaki H; Arisawa M Eur J Pharmacol; 1992 Oct; 221(1):99-105. PubMed ID: 1459194 [TBL] [Abstract][Full Text] [Related]
2. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities. Ohtsuka T; Kotaki H; Nakayama N; Itezono Y; Shimma N; Kudoh T; Kuwahara T; Arisawa M; Yokose K; Seto H J Antibiot (Tokyo); 1993 Jan; 46(1):11-7. PubMed ID: 8436543 [TBL] [Abstract][Full Text] [Related]
3. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization. Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation. Smith AJ; Patel S; Freedman SB Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481 [TBL] [Abstract][Full Text] [Related]
5. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation. Ohtsuka T; Nakayama N; Itezono Y; Shimma N; Kuwahara T; Yokose K; Seto H J Antibiot (Tokyo); 1993 Jan; 46(1):18-24. PubMed ID: 8436552 [TBL] [Abstract][Full Text] [Related]
6. Activation of CCK-B receptors elevates cytosolic Ca2+ levels in a pituitary cell line. Kuwahara T; Nagase H; Takamiya M; Yoshizaki H; Kudoh T; Nakano A; Arisawa M Peptides; 1993; 14(4):801-5. PubMed ID: 8234029 [TBL] [Abstract][Full Text] [Related]
7. Species specificity of pharmacological characteristics of CCK-B receptors. Kuwahara T; Kudoh T; Nakano A; Yoshizaki H; Takamiya M; Nagase H; Arisawa M Neurosci Lett; 1993 Aug; 158(1):1-4. PubMed ID: 8233061 [TBL] [Abstract][Full Text] [Related]
8. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Corp ES; McQuade J; Moran TH; Smith GP Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086 [TBL] [Abstract][Full Text] [Related]
9. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657 [TBL] [Abstract][Full Text] [Related]
10. Type B cholecystokinin receptors on rat glioma C6 cells. Binding studies and measurement of intracellular calcium mobilization. Kaufmann R; Lindschau C; Schöneberg T; Haller H; Henklein P; Boomgaarden M; Ott T Brain Res; 1994 Mar; 639(1):109-14. PubMed ID: 8180826 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line. Lignon MF; Bernad N; Martinez J Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor. Koizumi T; Saita Y; Miyake A; Nishida A; Yazawa H; Honda K Jpn J Pharmacol; 1996 Aug; 71(4):307-13. PubMed ID: 8886928 [TBL] [Abstract][Full Text] [Related]
13. CCKB receptor signaling in rat pituitary GH3 cells. CCK-8S-induced intracellular calcium mobilization by Ca2+ release and Ca2+ influx. Kaufmann R; Lindschau C; Schöneberg T; Henklein P; Boomgaarden M; Haller H; Ott T Neuropeptides; 1994 Oct; 27(4):211-6. PubMed ID: 7808593 [TBL] [Abstract][Full Text] [Related]
14. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists. Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955 [TBL] [Abstract][Full Text] [Related]
16. Comparative 3H-CCK-8S binding studies on CCKB-type receptors in guinea-pig cortex and continuous cell lines. Kaufmann R; Schöneberg T; Henklein P; Boomgaarden M; Sohr D; Ott T Neuropeptides; 1994 Jun; 26(6):429-33. PubMed ID: 7936128 [TBL] [Abstract][Full Text] [Related]
17. CCK-JMV-180 acts as an antagonist of the CCKA receptor in the human IMR-32 neuroblastoma cell line. Schaeffer P; Prabonnaud V; Roux M; Gully D; Herbert JM FEBS Lett; 1994 Nov; 354(2):203-6. PubMed ID: 7957924 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588 [TBL] [Abstract][Full Text] [Related]
19. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. I. Taxonomy, yield improvement and fermentation. Watanabe J; Fujisaki N; Fujimori K; Anzai Y; Oshima S; Sano T; Ohtsuka T; Watanabe K; Okuda T J Antibiot (Tokyo); 1993 Jan; 46(1):1-10. PubMed ID: 8436542 [TBL] [Abstract][Full Text] [Related]
20. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle. Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]